| Sources | Names Used |
|---|---|
| CTRPv2 | 16-beta-bromoandrosterone |
| PharmacoGx | 16-beta-bromoandrosterone |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZP3 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | ZPR1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ZRSR1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ZSCAN10 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | ZSCAN16 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | ZSCAN20 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | ZSCAN30 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | ZSWIM5 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | ZXDB | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | ZXDC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
